Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort
Renée T. Fortner(Heidelberg University), Rudolf Kaaks(German Cancer Research Center)
Cited by 29
Related Papers
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
|Proceedings of The Nutrition Society|2001|615
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status-Results from the EPIC cohort
|International Journal of Cancer|2013|90
Mitochondrial DNA copy number variation, leukocyte telomere length, and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
|Breast Cancer Research|2018|51
Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study
|Breast Cancer Research|2015|40